Evidence check: CYP1A2 in the context of Blutzucker

The provided context documents contain no direct information linking CYP1A2 to blood sugar. CYP1A2 is primarily known as the key enzyme in caffeine metabolism; its role in glucose regulation is inconsistently reported in the literature. Some studies suggest a possible interaction between CYP1A2 polymorphisms and caffeine intake in modulating diabetes risk, but findings are not robustly replicated. Associations with fasting glucose or HbA1c are not well established. Since the given sources (ACTN3, FTO, stool tests, fat metabolism genes) do not address CYP1A2, no evidence-based statement can be made from this context. The overall evidence level is weak to unclear. Consumers should be aware that direct-to-consumer genetic tests for CYP1A2 often make exaggerated claims not supported by solid clinical data.